Clorox Co. (CLX) to Issue $0.80 Quarterly Dividend
Clorox Co. (NYSE:CLX) declared a quarterly dividend on Tuesday, November 15th. Shareholders of record on Wednesday, January 25th will be given a dividend of 0.80 per share on Friday, February 10th. This represents a $3.20 annualized dividend and a yield of 2.80%.
Clorox (NYSE:CLX) opened at 114.18 on Wednesday. Clorox has a 12-month low of $111.24 and a 12-month high of $140.47. The firm has a 50-day moving average of $120.23 and a 200 day moving average of $128.40. The company has a market capitalization of $14.70 billion, a PE ratio of 22.98 and a beta of 0.36.
Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, November 2nd. The company reported $1.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.42 by $0.06. The business had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.24 billion. Clorox had a net margin of 11.27% and a return on equity of 250.82%. The firm’s quarterly revenue was up 3.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.32 earnings per share. Analysts forecast that Clorox will post $5.32 EPS for the current fiscal year.
In other news, SVP Jon M. Balousek sold 5,136 shares of the business’s stock in a transaction that occurred on Monday, August 29th. The shares were sold at an average price of $131.14, for a total value of $673,535.04. Following the sale, the senior vice president now owns 15,384 shares of the company’s stock, valued at $2,017,457.76. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Laura Stein sold 38,882 shares of the business’s stock in a transaction that occurred on Friday, September 2nd. The shares were sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the completion of the sale, the executive vice president now directly owns 48,501 shares in the company, valued at approximately $6,387,096.69. The disclosure for this sale can be found here. 0.74% of the stock is currently owned by company insiders.
Several hedge funds have recently bought and sold shares of CLX. State Street Corp raised its stake in Clorox by 2.4% in the second quarter. State Street Corp now owns 7,168,847 shares of the company’s stock valued at $992,096,000 after buying an additional 169,031 shares during the period. Janus Capital Management LLC raised its stake in Clorox by 17.1% in the second quarter. Janus Capital Management LLC now owns 1,989,769 shares of the company’s stock valued at $275,364,000 after buying an additional 290,125 shares during the period. APG Asset Management N.V. raised its stake in Clorox by 1.4% in the second quarter. APG Asset Management N.V. now owns 1,143,515 shares of the company’s stock valued at $158,251,000 after buying an additional 16,300 shares during the period. AQR Capital Management LLC raised its stake in Clorox by 29.4% in the second quarter. AQR Capital Management LLC now owns 772,451 shares of the company’s stock valued at $106,899,000 after buying an additional 175,330 shares during the period. Finally, Parametric Portfolio Associates LLC raised its stake in Clorox by 16.2% in the second quarter. Parametric Portfolio Associates LLC now owns 637,383 shares of the company’s stock valued at $88,207,000 after buying an additional 88,910 shares during the period. 69.89% of the stock is currently owned by institutional investors.
A number of research analysts have recently issued reports on the stock. B. Riley reiterated a “neutral” rating and set a $111.00 price objective on shares of Clorox in a report on Wednesday, November 9th. Zacks Investment Research cut shares of Clorox from a “buy” rating to a “hold” rating in a report on Tuesday, October 25th. RBC Capital Markets reiterated a “sector perform” rating and set a $115.00 price objective (down from $121.00) on shares of Clorox in a report on Thursday, November 3rd. Jefferies Group reiterated a “hold” rating on shares of Clorox in a report on Wednesday, August 3rd. Finally, Royal Bank Of Canada reduced their price objective on shares of Clorox from $121.00 to $115.00 and set a “sector perform” rating for the company in a report on Thursday, November 3rd. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $127.30.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Stock Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related stocks with our FREE daily email newsletter.